An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD
Clinical trial NCT00373659 · COMPLETED
Trial details
- NCT number
- NCT00373659
- Sponsor
- University of Miami
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2007-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.